Stock Report

Download full stock data and analysis for free Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Metropolis Health Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: METROPOLIS | BSE: 542650

₹588.70

up-down-arrow ₹-3.20 (-0.54%)

As on 04-Sep-2026 15:50IST

Market cap

info icon

₹12,235 Cr

Revenue (TTM)

info icon

₹1,710 Cr

P/E Ratio

info icon

60.7

P/B Ratio

info icon

7.8

Div. Yield

info icon

0.8 %

Edit peer-selector-edit
Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Market cap (₹ Cr)
 12,235 39,493 32,095 31,470 15,412
Revenue (₹ Cr)
 1,710 4,683 4,213 2,891 857
Net Profit (₹ Cr)
 202.82 552.34 190.80 546.30 187.49
Net Margin (%)
 11.70 11.55 4.49 18.23 21.32
RoE (%)
 14.13 14.93 9.45 23.03 20.58
Price to Earnings
 60.68 71.01 157.10 58.07 82.20
Price-To-Book
 7.85 9.61 8.48 12.04 15.30

Income Statement (₹ Cr)

Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Operating Revenue arrow
1,710.00 4,683.37 4,212.50 2,890.80 857.13
Total Income arrow
1,733.17 4,783.78 4,248.00 2,995.90 879.41
Total Expenditure arrow
1,287.72 3,704.62 3,379.70 2,053.10 495.19
EBITDA arrow
422.28 978.75 832.80 837.70 361.94
Depreciation arrow
135.28 246.41 330.60 171.60 96.06
EBIT arrow
287.00 732.34 502.20 666.10 265.89
Interest arrow
25.53 92.01 253.30 24.40 36.75
Other Income arrow
23.17 100.41 35.50 105.10 22.28
Exceptional Items arrow
-8.99 -20.61 -11.20 -30.10 0.00
Profit before Tax arrow
275.66 720.14 273.20 716.70 251.42
Provision for Tax arrow
72.84 167.80 82.40 170.40 63.93
Profit after Tax arrow
202.82 552.34 190.80 546.30 187.49

Liabilities (₹ Cr)

Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Shareholder's Funds arrow
1,513.16 3,961.57 2,247.40 2,508.20 957.15
Minority Interest arrow
-1.20 3.84 9.90 -4.40 0.00
Non-Current Liabilities arrow
279.48 1,293.60 3,961.30 154.00 426.03
Current Liabilities arrow
334.02 627.13 1,238.90 450.70 123.87
Total Liabilities arrow
2,524.76 5,905.00 7,690.70 3,139.97 1,507.05

Assets (₹ Cr)

Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Non-Current Assets arrow
1,415.30 3,128.95 5,416.90 1,176.30 737.24
Current Assets arrow
468.61 1,674.92 937.40 1,566.60 321.90
Total Assets arrow
2,524.76 5,905.00 7,690.70 3,139.97 1,507.05
Total Debt* arrow
18.73 631.08 3,244.00 0.00 0.00
Net Current Assets arrow
134.59 1,047.79 -301.50 1,115.90 198.03
Contingent Liabilities arrow
10.08 100.01 81.10 16.76 0.13

Cashflow (₹ Cr)

Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Cash From Operating Activities arrow
350.70 714.39 510.80 635.61 270.59
Cash Flow from Investing Activities arrow
-223.13 -1,089.11 -1,451.70 -421.86 -174.22
Cash from Financing Activities arrow
-115.29 271.85 940.30 -263.57 -69.49
Net Cash Inflow / Outflow arrow
12.28 -102.87 -0.60 -49.83 26.88

Ratios

Profitability Ratios

 Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
ROCE (%) arrow
20.03 19.38 11.51 29.56 30.28
ROE (%) arrow
14.13 14.93 9.45 23.03 20.58
ROA (%) arrow
10.13 10.35 2.83 18.64 13.49
EBIT Margin (%) arrow
16.78 15.64 11.92 23.04 31.02
Net Margin (%) arrow
11.70 11.55 4.49 18.23 21.32
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Revenue Growth (%) arrow
21.80 21.27 30.90 14.29 20.18
EBIT Growth (%) arrow
43.53 0.94 -16.88 15.64 26.22
Net Profit Growth (%) arrow
32.87 3.43 -52.81 5.38 24.27
EPS Growth (%) arrow
-16.64 2.70 -42.60 -30.51 23.44
Book Value Growth (%) arrow
13.54 16.51 5.13 15.41 21.86

Valuation Ratios

 Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Price / Earnings arrow
23.97 68.96 144.63 43.98 82.06
Price / Book Value arrow
7.85 9.61 8.48 12.04 15.30
Dividend Yield (%) arrow
0.85 0.03 0.00 1.09 0.13
EV/EBITDA arrow
28.54 39.84 42.33 35.98 41.80
Market Cap (₹ Cr) arrow
8,992.90 25,841.07 24,901.98 22,015.15 8,864.05

Solvency Ratios

 Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Debt to Equity arrow
0.00 0.15 1.19 0.00 0.00
Short term debt to equity ratio arrow
0.01 -- 0.15 -- --
Current Ratio arrow
1.40 2.67 0.76 3.48 2.60
Quick Ratio arrow
1.27 2.54 0.68 3.38 2.56
Interest Coverage arrow
11.80 8.83 2.08 30.37 7.84

Operating Efficiency Ratios

 Metropolis Health Global Health Krishna Institute Dr. Lal Pathlabs Vijaya Diagno
Debtors to sales (%) arrow
9.96 8.78 13.16 3.83 2.43
Asset Turnover arrow
0.85 0.88 0.62 0.99 0.62
Receivable days arrow
35.29 29.09 44.38 13.13 7.98
Inventory Days arrow
10.35 6.05 7.52 5.28 2.20
Payable days arrow
143.56 80.04 133.54 118.67 136.27
Cash Conversion Cycle arrow
-97.92 -44.90 -81.64 -100.26 -126.08
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...